HealthEquity, Inc. (NASDAQ:HQY) Holdings Decreased by Van Berkom & Associates Inc.

Key Points

• Van Berkom & Associates Inc. reduced its holdings in HealthEquity, Inc. by 22.5%, now owning 650,061 shares valued at approximately $57.4 million.
• HealthEquity reported a quarterly EPS of $0.97, exceeding analyst estimates of $0.81, with revenues reaching $330.8 million, surpassing the consensus of $322.25 million.
• Analysts have shown positive sentiment, with several firms raising their price targets for HealthEquity stock, now averaging $118.55, indicating a favorable outlook for the company.

Van Berkom & Associates Inc. reduced its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 22.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 650,061 shares of the company's stock after selling 188,260 shares during the period. Van Berkom & Associates Inc. owned about 0.75% of HealthEquity worth $57,446,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in HQY. Skandinaviska Enskilda Banken AB publ grew its position in shares of HealthEquity by 128.8% during the 1st quarter. Skandinaviska Enskilda Banken AB publ now owns 1,071 shares of the company's stock valued at $95,000 after buying an additional 603 shares during the last quarter. Assetmark Inc. boosted its stake in HealthEquity by 25.2% in the first quarter. Assetmark Inc. now owns 5,886 shares of the company's stock valued at $520,000 after acquiring an additional 1,184 shares during the period. ANB Bank bought a new position in shares of HealthEquity during the first quarter valued at approximately $200,000. Cetera Investment Advisers raised its position in shares of HealthEquity by 47.3% during the 1st quarter. Cetera Investment Advisers now owns 5,260 shares of the company's stock worth $465,000 after purchasing an additional 1,688 shares during the period. Finally, Avantax Advisory Services Inc. lifted its holdings in shares of HealthEquity by 9.0% in the 1st quarter. Avantax Advisory Services Inc. now owns 10,516 shares of the company's stock worth $929,000 after purchasing an additional 871 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Trading Up 1.8%

HealthEquity stock opened at $96.04 on Friday. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $116.65. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. The stock has a market capitalization of $8.31 billion, a PE ratio of 70.10, a price-to-earnings-growth ratio of 1.46 and a beta of 0.49. The firm has a 50 day simple moving average of $101.54 and a 200-day simple moving average of $98.43.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The firm had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. During the same period in the prior year, the firm posted $0.80 earnings per share. As a group, equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. JMP Securities upped their price objective on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research note on Wednesday, June 4th. Royal Bank Of Canada boosted their target price on shares of HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday, June 6th. The Goldman Sachs Group boosted their price objective on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 4th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, June 5th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $118.55.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of the business's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. The trade was a 3.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jon Kessler sold 134,183 shares of the firm's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the transaction, the director owned 253,510 shares of the company's stock, valued at approximately $28,413,400.80. This trade represents a 34.61% decrease in their position. The disclosure for this sale can be found here. Insiders sold 291,744 shares of company stock valued at $32,705,007 over the last 90 days. 1.50% of the stock is currently owned by corporate insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.